Mylan Return on Investment 2006-2019 | MYL
Current and historical return on investment (ROI) values for Mylan (MYL) over the last 10 years.
| Mylan ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2019-03-31 |
$0.77B |
$26.11B |
2.93% |
| 2018-12-31 |
$0.91B |
$26.43B |
3.41% |
| 2018-09-30 |
$1.09B |
$26.51B |
4.07% |
| 2018-06-30 |
$1.07B |
$26.58B |
3.97% |
| 2018-03-31 |
$1.37B |
$26.76B |
4.98% |
| 2017-12-31 |
$1.44B |
$27.41B |
5.20% |
| 2017-09-30 |
$1.33B |
$27.28B |
4.80% |
| 2017-06-30 |
$0.88B |
$28.23B |
3.26% |
| 2017-03-31 |
$0.82B |
$27.73B |
3.18% |
| 2016-12-31 |
$0.70B |
$27.68B |
2.99% |
| 2016-09-30 |
$0.81B |
$24.80B |
3.96% |
| 2016-06-30 |
$1.54B |
$23.10B |
8.32% |
| 2016-03-31 |
$1.41B |
$17.94B |
8.30% |
| 2015-12-31 |
$1.46B |
$16.06B |
8.84% |
| 2015-09-30 |
$1.43B |
$17.02B |
9.47% |
| 2015-06-30 |
$1.32B |
$16.84B |
9.85% |
| 2015-03-31 |
$1.27B |
$16.22B |
10.28% |
| 2014-12-31 |
$1.35B |
$10.31B |
11.89% |
| 2014-09-30 |
$1.23B |
$10.40B |
10.49% |
| 2014-06-30 |
$1.08B |
$12.57B |
9.24% |
| 2014-03-31 |
$1.16B |
$12.24B |
10.63% |
| 2013-12-31 |
$1.14B |
$11.82B |
11.14% |
| 2013-09-30 |
$1.13B |
$10.04B |
11.72% |
| 2013-06-30 |
$1.12B |
$9.61B |
12.04% |
| 2013-03-31 |
$1.07B |
$9.34B |
11.80% |
| 2012-12-31 |
$1.11B |
$9.46B |
12.29% |
| 2012-09-30 |
$1.09B |
$8.83B |
12.37% |
| 2012-06-30 |
$1.03B |
$8.75B |
11.76% |
| 2012-03-31 |
$1.04B |
$9.07B |
11.87% |
| 2011-12-31 |
$1.01B |
$8.73B |
11.44% |
| 2011-09-30 |
$0.85B |
$8.32B |
9.56% |
| 2011-06-30 |
$0.82B |
$9.06B |
8.97% |
| 2011-03-31 |
$0.74B |
$9.04B |
8.17% |
| 2010-12-31 |
$0.72B |
$9.25B |
8.10% |
| 2010-09-30 |
$0.69B |
$9.22B |
7.85% |
| 2010-06-30 |
$0.52B |
$8.49B |
5.98% |
| 2010-03-31 |
$0.50B |
$8.72B |
5.78% |
| 2009-12-31 |
$0.52B |
$8.62B |
6.24% |
| 2009-09-30 |
$0.50B |
$8.61B |
6.00% |
| 2009-06-30 |
$1.00B |
$8.30B |
12.08% |
| 2009-03-31 |
$0.90B |
$8.02B |
10.93% |
| 2008-12-31 |
$0.30B |
$8.29B |
3.62% |
| 2008-09-30 |
$-1.00B |
$8.44B |
-12.10% |
| 2008-06-30 |
$-1.47B |
$8.08B |
-20.92% |
| 2008-03-31 |
$-1.35B |
$8.13B |
-23.14% |
| 2007-12-31 |
$-0.99B |
$8.32B |
-21.28% |
| 2007-09-30 |
$0.67B |
$3.50B |
22.35% |
| 2007-06-30 |
$0.72B |
$3.42B |
28.03% |
| 2007-03-31 |
$0.65B |
$3.33B |
30.79% |
| 2006-12-31 |
$0.65B |
$1.81B |
39.93% |
| 2006-09-30 |
$0.56B |
$1.67B |
35.79% |
| 2006-06-30 |
$0.49B |
$1.58B |
31.11% |
| 2006-03-31 |
$0.43B |
$1.50B |
26.13% |
| 2005-12-31 |
$0.43B |
$1.55B |
24.73% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$8.773B |
$11.434B |
|
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
|
